Stay updated on IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial
Sign up to get notified when there's something new on the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page.

Latest updates to the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing the 'HHS Vulnerability Disclosure' link as well as the older 'Revision: v3.3.2'.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page's footer revision label was updated from v3.2.0 to v3.3.2, a minor site maintenance detail that does not affect trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedNotice about government funding status is removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check59 days agoChange DetectedThe new screenshot shows only a UI/layout refresh of the Record History page; no study content, identifiers, or status information appear to change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange Detected- Added a government notice about funding and operating status, and a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference8%

- Check94 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.2%

Stay in the know with updates to IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page.